
Hologic's Strong International Traction to Continue Despite Headwinds
HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.
Predicted Price is the pryogiTM prediction of where the price is going in next 3-4 quarters. There may be a revision of the predicted price every 3 months from the date of publication of the first predicted price of the stock. Price on Report Date is the price of the stock on the day prediction was published by pryogiTM. Current price shows the current price of the stock.
Margin of error shows range the price will end up in dollars either above or below the predicted price. Margin of error percentage shows the price will end up in percentage either above or below the predicted price.
Expected Returns from report date shows the returns (positive or negative) from published prediction date if you bought the stock on report date. Expected Returns from today shows the returns from today if you buy the stock today. A positive expected returns indicates a profit you will make, a negative expected return indicates a loss you will make if you buy the stock. There are different strategies to apply in the stock market for profit and loss, pryogiTM will publish such strategies in the future to help you.
PryogiTM meter shows you predicted price, price on the date this prediction was published(report date) and price of the stock today on a price scale. This indicates if the stock price is moving towards or away from the predicted price
PryogiTM performance chart shows actual movement of stock price from prediction published date(report date) and if the price is moving towards or away from predicted price
HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.
Banzai to Present at the Emerging Growth Conference on Wednesday, September ...
Shuimu BioSciences, a Chinese start-up specialising in advanced imaging devices for viruses and smaller biomolecules, is aiming for an initial public offering in 2027 after selling its first self-developed product this year, according to CEO Allen Guo Chunlong.
Thermo Fisher unveils the Olink Target 48 Neurodegeneration panel to accelerate biomarker research in neurodegenerative diseases.
HOLLISTON, Mass., Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Harvard Bioscience, Inc.
Zacks' strategies continue to outpace the market in 2025, with standout gains from CommScope, Micron, Oracle, and others across multiple model portfolios.
A report on September 11, 2025 shows that Representative Kelly Morrison from Minnesota sale stock in Accenture ACN, valued between $67,011 and $305,000. According to the September filing, the transaction occurred on August 19, 2025. At the time of writing, Accenture shares are trading down 1.24% ...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wells Fargo raised W. P. Carey Inc. WPC price target from $68 to $72.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Deutsche Bank analyst Lee Horowitz upgraded Chewy, Inc. CHWY from Hold to Buy and announced a ...
Banzai Completes $32.7 Million Debt and Liability Elimination Through August ...
$10.7 Million Repaid Year to Date and $32.7 Million Since September 2024 Obligation Debt Reduction Initiatives Adding Material Benefit to Net Income and Shareholders' Equity SEATTLE, Sept. 05, 2025 ( GLOBE NEWSWIRE ) -- Banzai International, Inc.
Banzai Completes $32.7 Million Debt and Liability Elimination Through August ...
Burlingame, CA, Sept. 04, 2025 ( GLOBE NEWSWIRE ) -- The Global DNA Manufacturing Market is estimated to be valued at USD 6.44 Bn in 2025 and is expected to reach USD 19.56 Bn by 2032, exhibiting a compound annual growth rate ( CAGR ) of 17.2% from 2025 to 2032.
HOLX's Panther Fusion expands its diagnostics menu, fueling assay growth and unlocking more upside in molecular testing.
RBC Capital upgraded Bio-Techne to Outperform and lifted its price target from $61 to $73. Bio-Techne shares are down 26% over the past year and 25% year-to-date. Get Discounted Real-Time Trade Alerts For a Volatile Market ( Labor Day Special )
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Banzai to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September ...
Investors seemed unhappy about some major spending news from the company.
Even in a choppy market, Zacks' strategies are spotlighting winners like Oracle, Intellia, and Pharming Group, proving the value of a disciplined, research-driven approach.
Looking into the current session, Thermo Fisher Scientific Inc. TMO shares are trading at $492.72, after a 0.61% spike. Moreover, over the past month, the stock went up by 5.64%, but in the past year, fell by 18.75%.
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TMO's growth, driven by new partnerships and strong end markets, faces challenges from macro pressures and fierce competition.
Thermo Fisher Scientific TMO has outperformed the market over the past 20 years by 6.79% on an annualized basis producing an average annual return of 15.43%. Currently, Thermo Fisher Scientific has a market capitalization of $185.14 billion.
Austin, TX, USA, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "Chemical Reagents Market Size, Trends and Insights By Product Type ( Solvents, Acids & Bases, Oxidizing & Reducing Agents, Buffers & Standards, Catalysts ) , By Application ( ...
Lewes, Delaware, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- The Global Biobanking Market Size is projected to grow at a CAGR of 9.89% from 2024 to 2031, according to a new report published by Verified Market Research®.
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Austin, TX, USA, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "Induced Pluripotent Stem Cells Production Market Size, Trends and Insights By Process ( Manual iPSC Production, Automated iPSC Production ) , By Workflow ( Cell Culture, Cell ...
Boston, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, the "Genome Editing: Technologies and Global Markets" is projected to grow from $10.8 billion in 2025 to $23.7 billion by the end of 2030, at a compound annual growth rate ( CAGR ) of 16.9% during the ...
According to one pundit, the company has a hard-to-beat mix of quality products and services.
Thermo Fisher stock is projected to reach $598 by 2026, offering 22% upside. Shares have fallen 27% since 2021, trailing the S&P's 30% gain, but the long-term outlook is strong. Get more market-moving news first with AI-powered analysis that turns noise into opportunity.
Biodesix recently validated Thermo Fisher's tissue-based Oncomine Dx Express Test for solid tumors on the Genexus Dx Integrated Sequencer Biodesix recently validated Thermo Fisher's tissue-based Oncomine Dx Express Test for solid tumors on the Genexus Dx Integrated Sequencer ...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
IBM, Goldman Sachs and Thermo Fisher stand out in Zacks research with AI growth, strong banking results and new product launches.
AUSTIN, Texas, Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- Astrotech Corporation ( Nasdaq: ASTC ) ( the "Company" or "Astrotech" ) , today announced that it has appointed Nihanth Badugu as Chief Operating Officer ( "COO" ) of the Company. Mr. Badugu's appointment is effective as of August 13, 2025.
Investors with a lot of money to spend have taken a bearish stance on Thermo Fisher Scientific TMO. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
CBRE, Acadian, and Fastenal highlight Zacks' market-beating picks as portfolios outpace broader indexes with strong 2025 gains.
Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
On CNBC's "Halftime Report Final Trades," Ritholtz Wealth Management CEO Joshua Brown named Toast, Inc. TOST following the release of quarterly results. On Aug. 5, the company reported quarterly earnings of 13 cents per share. It exceeded the analyst consensus estimate of 11 cents per share.
SEATTLE, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- ( NASDAQ: BNZI ) ( "Banzai" or the "Company" ) , a leading marketing technology company that provides essential marketing and sales solutions, today announced the appointment of Matt McCurdy as Vice President of Sales to lead strategic growth and ...
Austin, TX, USA, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "AI in Synthetic Biology Market Size, Trends and Insights By Technology ( Gene Synthesis, Genome Editing, Synthetic Biology Tools, Bioinformatics ) , By Application ( Healthcare ...
Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings ...
Engine estimates Avantor's strategic value at $17-$19 per share, a 50% premium. LSS margins trail Thermo Fisher's comparable division by 450 basis points. This simple system has nailed 1,000+ post-earnings winners. Get in before Q3 trades take off → Avantor Inc.
Lewes, Delaware, Aug. 11, 2025 ( GLOBE NEWSWIRE ) -- The Global Veterinary Diagnostics Market Size is projected to grow at a CAGR of 6.59% from 2024 to 2031, according to a new report published by Verified Market Research®.
Burlingame, CA, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- The global Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn in 2032, exhibiting a compound annual growth rate ( CAGR ) of 8.7% from 2025 to 2032.
Boston, Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, the "Global Markets for Allergy Diagnostics and Treatments" is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual growth rate ( CAGR ) of 7.3% from ...
SEATTLE, Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- ( NASDAQ: BNZI ) ( "Banzai" or the "Company" ) , a leading marketing technology company that provides essential marketing and sales solutions, will hold a conference call on Thursday, August 14, 2025, at 4:30 p.m.
SEATTLE, Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- Banzai International, Inc. BNZI ( "Banzai" or the "Company" ) , a leading marketing technology company that provides essential marketing and sales solutions, will hold a conference call on Thursday, August 14, 2025, at 4:30 p.m.
FDA-cleared PreClara™ Ratio ( sFlt-1/PlGF ) biomarker test offers clinicians a crucial tool for managing hypertensive disorders of pregnancy, with potential significant cost savings and improved patient outcomes
FDA-cleared PreClara™ Ratio ( sFlt-1/PlGF ) biomarker test offers clinicians a crucial tool for managing hypertensive disorders of pregnancy, with potential significant cost savings and improved patient outcomes ...